换一批
换一批Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
作者：
Johannes,Lorscheider [1]
;
Alessio,Signori [2]
;
Suvitha,Subramaniam [3]
;
Pascal,Benkert [3]
;
Sandra,Vukusic [4]
;
Maria,Trojano [5]
;
Jan,Hillert [6]
;
Anna,Glaser [6]
;
Robert,Hyde [7]
;
Tim,Spelman [8]
;
Melinda,Magyari [9]
;
Frederik,Elberling [10]
;
Luigi,Pontieri [10]
;
Nils,Koch-Henriksen [11]
;
Per Soelberg,Sørensen [10]
;
Oliver,Gerlach [12]
;
Alexandre,Prat [13]
;
Marc,Girard [13]
;
Sara,Eichau [14]
;
Pierre,Grammond [15]
;
Dana,Horakova [16]
;
Cristina,Ramo-Tello [17]
;
Izanne,Roos [18]
;
Katherine,Buzzard [19]
;
Jeanette,Lechner Scott [20]
;
José Luis,Sánchez-Menoyo [21]
;
Raed,Alroughani [22]
;
Julie,Prévost [23]
;
Jens,Kuhle [24]
;
Orla,Gray [25]
;
Guillaume,Mathey [26]
;
Laure,Michel [27]
;
Jonathan,Ciron [28]
;
Jérôme,De Sèze [29]
;
Elisabeth,Maillart [30]
;
Aurelie,Ruet [31]
;
Pierre,Labauge [32]
;
Helene,Zephir [33]
;
Arnaud,Kwiatkowski [34]
;
Anneke,van der Walt [35]
;
Tomas,Kalincik [18]
;
Helmut,Butzkueven [35]
;
Italian MS Register ;
Observatoire Français de la Sclérose en Plaques (OFSEP) ;
MSBase Study Group ;
Swedish MS Registry ;
Big MS Data Network
作者单位：
Department of Neurology, University Hospital Basel, Basel, Switzerland johannes.lorscheider@usb.ch.;Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University of Basel, Basel, Switzerland.
[1]
Department of Health Sciences, Section of Biostatistics, University of Genoa, Genova, Italy.
[2]
Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
[3]
Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Lyon, France.;Université de Lyon, Lyon, France.;Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, Lyon, France.;Eugène Devic EDMUS Foundation against multiple sclerosis, Lyon, France.
[4]
Department of Translational Biomedicine and Neurosciences - DiBraiN, University of Bari "Aldo Moro", Bari, Italy.
[5]
Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
[6]
Independent Healthcare and Real-World Evidence Consultant, Zug, Switzerland.
[7]
Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.;MSBase Foundation, Melbourne, Victoria, Australia.
[8]
Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital - Rigshospitalet Glostrup, Glostrup, Denmark.;Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
[9]
Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital - Rigshospitalet Glostrup, Glostrup, Denmark.
[10]
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
[11]
Academic MS Center Zuyd, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, Netherlands.;School for Mental Health and Neuroscience, Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.
[12]
Hôpital Notre Dame, CHUM and Universite de Montreal, Montreal, Quebec, Canada.
[13]
Hospital Universitario Virgen Macarena, Sevilla, Spain.
[14]
Hotel-Dieu de Levis, Levis, Quebec, Canada.
[15]
Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic.
[16]
Neurosciences, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
[17]
Clinical Outcomes Research Unit (CORe), Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.;Department of Neurology, Neuroimunology Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
[18]
Department of Neurosciences, Box Hill Hospital, Box Hill, Victoria, Australia.;Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
[19]
Hunter New England Health, John Hunter Hospital, Newcastle, New South Wales, Australia.;Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia.
[20]
Neurology, Galdakao Hospital, Spain, Spain.
[21]
Amiri Hospital, Kuwait City, Kuwait.
[22]
Centre Integre de Sante et de Services Sociaux des Laurentides, Saint-Jerome, Quebec, Canada.
[23]
Department of Neurology, University Hospital Basel, Basel, Switzerland.;Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University of Basel, Basel, Switzerland.
[24]
South Eastern HSC Trust, Belfast, UK.
[25]
Department of Neurology, Nancy University Hospital, Université de Lorraine, Nancy, France.
[26]
Centre Hospitalier Universitaire de Rennes, Rennes, France.
[27]
Department of Neurology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
[28]
Department of Neurology and Clinical Investigation Center, CHU de Strasbourg and University of Strasbourg, Strasbourg, France.
[29]
Neurology, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.
[30]
Service de Neurologie, CHU de Bordeaux, Bordeaux, France.;Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
[31]
CHU de Montpellier, MS Unit, University of Montpellier (MUSE), Montpellier, France.
[32]
CHU Lille, CRCSEP Lille, Université de Lille, Lille, France.
[33]
Department of Neurology, Hôpital Saint Vincent de Paul, Lille, France.
[34]
Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.;Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
[35]
DOI
10.1136/jnnp-2024-334700
PMID
39643429
发布时间
2025-01-11
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
